Auf dieser Seite
RIGL Rigel Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$47,15
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$24,9552-Wochen-Tief
$52,2452-Wochen-Hoch
Marktkapitalisierung
$863M
P/E (TTM)
2.8
EPS (TTM)
$16.89
Umsatz (TTM)
$277M
Ihre Abzeichen
52W-Spanne
$25–$52
Analystenbewertung
STRONG BUY
Kursziel
$63
P/E
2.8
ROE
126.9%
Nettogewinnmarge
116.3%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
RIGL Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$47.15
Marktkapitalisierung
$863M
P/E (TTM)
2.8
EPS (TTM)
$16.89
Umsatz (TTM)
$277M
ROE (TTM)
126.9%
52W-Spanne
$25–$52
RIGL Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 27. Juni 2024 | 1-for-10 | Umgekehrt |
| 25. Juni 2003 | 1-for-9 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$294M2016-12-31 → 2025-12-31
EPS$19.482019-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2022-12-31
Nettogewinnmarge116.3%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | RIGL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 2.85-Jahres-Durchschnitt ≈-47.2 | ≈-47.2 | · | · | |
| P/S | 2.95-Jahres-Durchschnitt ≈15.6 | ≈15.6 | 12.6 | Unterbewertet | |
| P/B (K/B) | 2.25-Jahres-Durchschnitt ≈-7.4 | ≈-7.4 | 4.6 | Unterbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | 11.45-Jahres-Durchschnitt ≈63.4 | ≈63.4 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 2.4 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | RIGL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 31.5%5-Jahres-Durchschnitt ≈-3.2% | ≈-3.2% | -180.0% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 32.4%5-Jahres-Durchschnitt ≈-2.2% | ≈-2.2% | -180.0% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 30.9%5-Jahres-Durchschnitt ≈-6.0% | ≈-6.0% | -170.5% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 116.3%5-Jahres-Durchschnitt ≈10.5% | ≈10.5% | -170.6% | Spitzenklasse | |
| ROA (TTM) | 88.5%5-Jahres-Durchschnitt ≈9.8% | ≈9.8% | -39.1% | Spitzenklasse | |
| ROE (TTM) | 126.9%5-Jahres-Durchschnitt ≈47.1% | ≈47.1% | -50.7% | Spitzenklasse | |
| ROIC | 96.5%5-Jahres-Durchschnitt ≈251.5% | ≈251.5% | -59.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | RIGL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.95-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 11.7 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 1.65-Jahres-Durchschnitt ≈1.9 | ≈1.9 | 4.9 | Unterdurchschnittlich |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | RIGL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 64.1%5-Jahres-Durchschnitt ≈26.5% | ≈26.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 34.8%5-Jahres-Durchschnitt ≈14.5% | ≈14.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 22.1% | · | · | · | |
| EPS YoY (EPS VjV) | 1867.7% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | 1999.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | RIGL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.95-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 0.5 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 2.25-Jahres-Durchschnitt ≈1.4 | ≈1.4 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 6.35-Jahres-Durchschnitt ≈5.7 | ≈5.7 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.7M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
111.8%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $0.88 | $0.63 | 39.2% |
| 31. März 2026 | $0.44 | $0.78 | -43.2% | |
| 31. Dezember 2025 | $1.15 | $1.27 | -9.6% | |
| 30. September 2025 | $1.46 | $0.87 | 67.5% | |
| 30. Juni 2025 | $3.28 | $2.63 | 24.6% | |
| 31. März 2025 | $0.63 | $0.09 | 592.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $294M | $179M | $117M | $120M | $149M | $109M | $59M | $45M | $4M | $20M | |
| Cost of Revenue | $20M | $19M | $7M | $2M | $1M | $895.0K | $906.0K | $287.0K | · | · | |
| R&D Expense | $33M | $23M | $25M | · | · | · | · | · | · | · | |
| SG&A Expense | $116M | $113M | $106M | $112M | $92M | $77M | $75M | $70M | $38M | $21M | |
| Operating Expenses | $169M | $155M | $137M | $176M | $162M | $138M | $128M | $117M | $84M | $90M | |
| Operating Income | $125M | $24M | $-20M | $-56M | $-12M | $-29M | $-69M | $-73M | $-80M | $-70M | |
| Interest Expense | · | $8M | $7M | $4M | $5M | $1M | $335.0K | · | · | · | |
| Interest Income | $4M | $2M | $2M | $684.0K | $47.0K | $582.0K | $3M | $2M | $892.0K | $437.0K | |
| Pretax Income | $122M | $18M | $-25M | $-59M | $-17M | $-30M | $-67M | · | · | · | |
| Income Tax | $-245M | $881.0K | $0 | · | $605.0K | · | · | $0 | $0 | $0 | |
| Net Income | $367M | $17M | $-25M | $-59M | $-18M | $-30M | $-67M | $-70M | $-78M | $-69M | |
| EPS (Basic) | $20.40 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · | |
| EPS (Diluted) | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · | |
| Shares (Basic) | 17,987,000 | 17,579,000 | 17,401,000 | 17,049,000 | 170,492,000 | 168,754,000 | 167,400,000 | · | · | · | |
| Shares (Diluted) | 18,840,000 | 17,687,000 | 17,401,000 | 17,049,000 | 170,492,000 | 168,754,000 | 167,400,000 | · | · | · | |
| EBITDA | $128M | $26M | $-19M | $-55M | $-11M | $-28M | $-68M | $-72M | · | $-69M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $57M | $33M | $24M | $19M | $30M | $23M | $76M | $38M | $18M | |
| Short-term Investments | $114M | $21M | $24M | $34M | $106M | $27M | $76M | $52M | $77M | $57M | |
| Receivables | $52M | $42M | $31M | $40M | $15M | $16M | $10M | $4M | $0 | $0 | |
| Inventory | $12M | $6M | $6M | $9M | $7M | $2M | $1M | $894.0K | · | · | |
| Prepaid Expense | $22M | $10M | $6M | $8M | $7M | $14M | $9M | $3M | $2M | $1M | |
| Other Current Assets | $5M | $5M | · | · | · | · | · | · | · | · | |
| Current Assets | $240M | $135M | $99M | $116M | $154M | $89M | $119M | $137M | $117M | $76M | |
| PP&E (Net) | $30.0K | $92.0K | $165.0K | $857.0K | $2M | $3M | $2M | $1M | $875.0K | $1M | |
| PP&E (Gross) | $347.0K | $353.0K | $2M | $12M | $17M | $16M | $15M | $14M | $13M | $20M | |
| Accum. Depreciation | $317.0K | $261.0K | $2M | $11M | $15M | $14M | $13M | $13M | $12M | $19M | |
| Intangibles | $25M | $27M | $14M | $15M | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $640.0K | $974.0K | $824.0K | $696.0K | $735.0K | $803.0K | $764.0K | |
| Total Assets | $514M | $164M | $117M | $134M | $167M | $110M | $148M | $139M | $119M | $78M | |
| Accounts Payable | $7M | $3M | $7M | $23M | $4M | $4M | $4M | $6M | $3M | $6M | |
| Accrued Liabilities | · | · | · | · | $4M | $4M | $3M | · | · | · | |
| Current Liabilities | $99M | $63M | $53M | $65M | $64M | $41M | $58M | $28M | $18M | $23M | |
| Capital Leases | $395.0K | $0 | $285.0K | $972.0K | $759.0K | $11M | $19M | · | · | · | |
| Other Non-current Liabilities | $0 | $40M | $40M | $42M | $53M | $5M | $5M | · | $38.0K | $2.0K | |
| Total Liabilities | $122M | $161M | $146M | $148M | $137M | · | · | · | · | · | |
| Long-term Debt | $52M | $60M | $60M | $40M | $20M | $20M | $10M | · | · | · | |
| Common Stock | $18.0K | $18.0K | $17.0K | $174.0K | $172.0K | $169.0K | $168.0K | $167.0K | $147.0K | $100.0K | |
| Retained Earnings | $-1.02B | $-1.39B | $-1.41B | $-1.38B | $-1.32B | $-1.31B | $-1.28B | $-1.21B | $-1.14B | $-1.06B | |
| AOCI | $181.0K | $10.0K | $8.0K | $-153.0K | $-102.0K | $-4.0K | $23.0K | $-24.0K | $-82.0K | $-18.0K | |
| Stockholders' Equity | $391M | $3M | $-29M | $-14M | $30M | $34M | $54M | $110M | $101M | $55M | |
| Liabilities + Equity | $514M | $164M | $117M | $134M | $167M | $110M | $148M | $139M | $119M | $78M | |
| Shares Outstanding | 18,310,934 | 17,710,216 | 17,482,513 | 173,398,645 | 171,602,226 | 169,316,782 | 167,987,850 | 167,171,505 | 146,814,906 | 99,269,418 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $998.0K | $1M | $706.0K | $683.0K | $594.0K | $465.0K | $941.0K | |
| Stock-based Comp | $13M | $12M | $9M | $12M | $9M | $7M | $9M | $8M | $6M | $7M | |
| Deferred Tax | $-246M | $0 | $0 | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $2M | $2M | $1M | $100.0K | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | · | $6M | |
| Other Non-cash | $-61M | $-635.0K | $9M | $-29M | $13M | $-30M | $16M | $3M | · | · | |
| Operating Cash Flow | $76M | $31M | $-6M | $-74M | $6M | $-52M | $-42M | $-59M | $-78M | $-76M | |
| CapEx | · | · | · | $450.0K | $627.0K | $1M | $1M | $1M | $164.0K | $804.0K | |
| Investing Cash Flow | $-92M | $4M | $-4M | $73M | $-80M | $47M | $-24M | $25M | $-19M | $25M | |
| Stock Issued | · | · | · | · | · | · | · | $67M | $114M | $24M | |
| Net Stock Activity | · | · | · | · | · | · | · | $67M | · | $30M | |
| Financing Cash Flow | $601.0K | $-12M | $18M | $7M | $63M | $13M | $11M | $72M | $118M | $25M | |
| Net Change in Cash | · | · | · | · | · | · | · | $38M | $21M | $-26M | |
| Taxes Paid | $1M | $331.0K | $81.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-74M | $5M | $-53M | $-43M | $-60M | · | $-77M | |
| Levered FCF | · | · | · | · | $221.1K | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% | -26.7% | -116.5% | -163.3% | · | · | |
| Net Margin | 124.7% | 9.8% | -21.5% | -48.7% | -12.0% | -27.4% | -112.8% | -158.3% | · | · | |
| Pretax Margin | 41.4% | 10.2% | -21.5% | -48.7% | -11.6% | · | · | · | · | · | |
| EBITDA Margin | 43.5% | 14.7% | -16.5% | -45.4% | -7.6% | -26.0% | -115.4% | -162.0% | · | · | |
| ROA | 108.3% | 12.4% | -20.0% | -38.8% | -12.9% | -23.1% | -46.7% | -54.6% | · | · | |
| ROE | 155.1% | -308.2% | 83.0% | 350.2% | -44.8% | -70.0% | -109.0% | -66.1% | · | · | |
| ROIC | 96.5% | 700.5% | · | · | -42.6% | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.1 | 1.9 | 1.8 | 2.4 | 2.2 | 2.0 | 4.9 | · | 3.4 | |
| Quick Ratio | 2.1 | 1.9 | 1.6 | 1.5 | 2.2 | 1.8 | 1.9 | 4.8 | · | 3.3 | |
| Interest Coverage | · | 3.1 | -3.0 | -15.0 | -2.6 | -21.4 | -206.2 | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.3 | 0.9 | 0.8 | 1.1 | 0.8 | 0.4 | 0.3 | · | · | |
| Inventory Turnover | 2.2 | 3.2 | 1.0 | 0.2 | 0.3 | 0.6 | 0.8 | 0.6 | · | · | |
| Receivables Turnover | 6.3 | 5.0 | 3.3 | 4.3 | 9.5 | 8.3 | 8.4 | 21.8 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.38 | $0.19 | $-0.16 | $-0.08 | $0.18 | $0.20 | $0.32 | $0.66 | · | $0.55 | |
| Revenue / Share | $15.62 | $10.14 | $0.67 | $0.70 | $0.88 | · | · | · | · | · | |
| Cash Flow / Share | $4.02 | $1.78 | $-0.03 | $-0.43 | $0.03 | · | · | · | · | · | |
| Cash / Share | $2.22 | $3.20 | $0.19 | $0.14 | $0.11 | $0.18 | $0.13 | $0.46 | · | $0.18 | |
| EPS (TTM) | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 64.1% | 53.4% | -2.8% | -19.4% | 37.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 34.8% | 6.3% | 2.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 22.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1867.7% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1999.1% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $294M | $179M | $117M | $120M | $149M | $109M | $59M | $45M | $4M | $20M | |
| Net Income TTM | $367M | $17M | $-25M | $-59M | $-18M | $-30M | $-67M | $-70M | $-78M | $-69M | |
| Market Cap | $784M | $298M | $2.53B | $2.60B | $4.55B | $5.93B | $3.59B | $3.84B | · | $2.36B | |
| P/E | 2.2 | 17.0 | -10.1 | -4.4 | -240.9 | -194.4 | -53.5 | · | · | · | |
| P/S | 2.7 | 1.7 | 21.7 | 21.6 | 30.5 | 54.6 | 60.6 | 86.4 | · | 115.9 | |
| P/B | 2.0 | 90.6 | -88.5 | -191.0 | 149.7 | 174.2 | 66.8 | 35.0 | · | 42.9 | |
| P / Tangible Book | 2.1 | · | · | · | 149.7 | 174.2 | · | · | · | · | |
| P / Cash Flow | 10.4 | 9.5 | -441.4 | -35.3 | 773.6 | -113.6 | -86.6 | -65.4 | · | -31.1 | |
| P / FCF | · | · | · | -35.0 | 866.0 | -110.9 | -83.7 | -64.2 | · | -30.8 | |
| Earnings Yield | 45.5% | 5.9% | -9.9% | -22.9% | -0.42% | -0.51% | -1.9% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $79M | $59M | $70M | $69M | $102M | $53M | $58M | $55M | $37M | $30M | $28M | $27M | $26M | $22M | $30M | $17M | |
| Cost of Revenue | $9M | $5M | $6M | $5M | $5M | $4M | $6M | $8M | $3M | $2M | $1M | $1M | $977.0K | $250.0K | $1M | $121.0K | |
| R&D Expense | $14M | $12M | · | · | $7M | $8M | · | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $33M | $31M | $30M | $29M | $29M | $28M | $30M | $27M | $28M | $28M | $25M | $26M | $28M | $26M | $27M | $27M | |
| Operating Expenses | $55M | $47M | $47M | $41M | $41M | $41M | $41M | $41M | $36M | $36M | $33M | $32M | $39M | $41M | $43M | $43M | |
| Operating Income | $24M | $12M | $23M | $28M | $61M | $13M | $17M | $14M | $447.0K | $-7M | $-4M | $-5M | $-13M | $-18M | $-13M | $-26M | |
| Interest Expense | · | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | $2M | $2M | $1M | $826.0K | $569.0K | $1M | |
| Interest Income | $789.0K | $1M | $1M | $1M | $753.0K | $591.0K | $522.0K | $425.0K | $552.0K | $593.0K | $672.0K | $529.0K | $393.0K | $192.0K | $42.0K | $21.0K | |
| Pretax Income | $24M | $12M | $23M | $28M | $60M | $12M | $15M | $12M | $-1M | $-8M | · | · | · | $-19M | $-13M | $-27M | |
| Income Tax | $6M | $3M | $-245M | $-280.0K | $369.0K | $65.0K | $881.0K | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | |
| Net Income | $17M | $9M | $268M | $28M | $60M | $11M | $14M | $12M | $-1M | $-8M | $-6M | $-7M | $-14M | $-19M | $-13M | $-27M | |
| EPS (Basic) | $0.93 | $0.47 | $14.88 | $1.55 | $3.33 | $0.64 | $0.81 | $0.71 | $-0.06 | $-0.47 | $-0.33 | $-0.38 | $-0.08 | $-0.11 | $-0.08 | $-0.16 | |
| EPS (Diluted) | $0.88 | $0.44 | $14.11 | $1.46 | $3.28 | $0.63 | $0.82 | $0.70 | $-0.06 | $-0.47 | $-0.33 | $-0.38 | $-0.08 | $-0.11 | $-0.08 | $-0.16 | |
| Shares (Basic) | 18,541,000 | 18,412,000 | · | 18,038,000 | 17,885,000 | 17,808,000 | · | 17,600,000 | 17,549,000 | 17,520,000 | 17,436,000 | 17,356,000 | 173,568,000 | 172,836,000 | 172,147,000 | 171,774,000 | |
| Shares (Diluted) | 19,570,000 | 19,686,000 | · | 19,156,000 | 18,162,000 | 18,169,000 | · | 17,648,000 | 17,549,000 | 17,520,000 | 17,436,000 | 17,356,000 | 173,568,000 | 172,836,000 | 172,147,000 | 171,774,000 | |
| EBITDA | $24M | $12M | · | $28M | $61M | $13M | · | $14M | $447.0K | $-7M | $-4M | $-5M | $-12M | $-18M | $-13M | $-26M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $24M | $41M | $49M | $53M | $46M | $57M | $52M | $36M | $26M | $45M | $49M | $40M | $30M | $27M | $25M | |
| Short-term Investments | $35M | $122M | $114M | $89M | $55M | $31M | $21M | $9M | $13M | $24M | $17M | $16M | $18M | $52M | $62M | $83M | |
| Receivables | $56M | $50M | $52M | $46M | $40M | $42M | $42M | $31M | $29M | $28M | $24M | $21M | $29M | $16M | $17M | $15M | |
| Inventory | $14M | $12M | $12M | $13M | $10M | $5M | $6M | $5M | $8M | $7M | $6M | $11M | $11M | $7M | $6M | $7M | |
| Prepaid Expense | $20M | $26M | $22M | $19M | $17M | $23M | $10M | $10M | $9M | $9M | $3M | $5M | $8M | $6M | $8M | $9M | |
| Other Current Assets | $5M | $7M | $5M | $6M | $5M | $6M | $5M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $186M | $234M | $240M | $215M | $175M | $147M | $135M | $106M | $95M | $92M | $95M | $101M | $107M | $110M | $121M | $139M | |
| PP&E (Net) | · | · | $30.0K | $54.0K | $57.0K | $76.0K | $92.0K | $99.0K | $115.0K | $140.0K | $190.0K | $215.0K | $294.0K | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $347.0K | · | · | · | $353.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $317.0K | · | · | · | $261.0K | · | · | · | · | · | · | · | · | · | |
| Intangibles | $94M | $24M | $25M | $25M | $26M | $27M | $27M | $28M | $28M | $29M | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $2M | $1M | $4M | $2M | $2M | $5M | $5M | $4M | $5M | $541.0K | $542.0K | $484.0K | $403.0K | $464.0K | |
| Total Assets | $521M | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M | $127M | $115M | $117M | $124M | $116M | $128M | $149M | |
| Accounts Payable | $4M | $4M | $7M | $4M | $7M | $4M | $3M | $4M | $6M | $9M | $8M | $5M | $6M | $3M | $2M | $5M | |
| Current Liabilities | $96M | $89M | $99M | $94M | $87M | $67M | $63M | $54M | $59M | $73M | $48M | $44M | $46M | $47M | $55M | $59M | |
| Capital Leases | $58.0K | $228.0K | $395.0K | $556.0K | $714.0K | $864.0K | $0 | · | · | $100.0K | $466.0K | $628.0K | $802.0K | · | · | · | |
| Other Non-current Liabilities | · | · | $0 | · | · | $40M | $40M | $40M | $40M | $40M | $39M | $41M | $42M | $49M | $47M | $53M | |
| Total Liabilities | $96M | $105M | $122M | $125M | $125M | $157M | $161M | $154M | $158M | $158M | $147M | $145M | $148M | · | · | · | |
| Long-term Debt | · | $45M | $52M | $60M | $60M | $60M | · | $60M | $60M | $60M | $60M | $60M | $60M | $40M | $30M | $30M | |
| Common Stock | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $175.0K | $175.0K | $175.0K | $174.0K | $173.0K | $173.0K | $172.0K | |
| Retained Earnings | $-997M | $-1.01B | $-1.02B | $-1.29B | $-1.32B | $-1.38B | $-1.39B | $-1.40B | $-1.42B | $-1.42B | $-1.41B | $-1.40B | $-1.40B | $-1.38B | $-1.36B | $-1.35B | |
| AOCI | $-148.0K | $-128.0K | $181.0K | $96.0K | $6.0K | $-2.0K | $10.0K | $11.0K | $-9.0K | $-5.0K | $-15.0K | $-25.0K | $-27.0K | $-286.0K | $-438.0K | $-416.0K | |
| Stockholders' Equity | $425M | $400M | $391M | $118M | $82M | $19M | $3M | $-15M | $-30M | $-32M | $-32M | $-28M | $-24M | $-20M | $-4M | $7M | |
| Liabilities + Equity | $521M | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M | $127M | $115M | $117M | $124M | $116M | $128M | $149M | |
| Shares Outstanding | · | · | 18,310,934 | · | · | · | 17,710,216 | · | · | · | · | · | · | · | · | · |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $848.0K | $597.0K | $601.0K | $603.0K | $607.0K | $604.0K | $604.0K | $611.0K | $613.0K | $400.0K | $292.0K | $296.0K | $357.0K | $240.0K | $237.0K | $237.0K | |
| Stock-based Comp | $7M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $5M | $2M | $2M | $3M | $3M | $2M | $3M | |
| Amort. of Intangibles | · | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $500.0K | $600.0K | $600.0K | $400.0K | $300.0K | $300.0K | $300.0K | · | · | · | |
| Other Non-cash | · | $-10M | · | · | · | $-16M | · | · | · | $-2M | · | · | $6M | · | · | $-2M | |
| Operating Cash Flow | $31M | $3M | $22M | $24M | $31M | $-893.0K | $15M | $22M | $302.0K | $-5M | $-1M | $6M | $-4M | $-13M | $-13M | $-26M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $189.0K | $-36.0K | $224.0K | |
| Investing Cash Flow | $17M | $-8M | $-25M | $-33M | $-23M | $-11M | $-11M | $4M | $11M | $313.0K | $-1M | $3M | $777.0K | $10M | $21M | $23M | |
| Stock Repurchased | $511.0K | $4M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-12M | $-11M | $-5M | $4M | $418.0K | $484.0K | $1M | $-10M | $-752.0K | $-3M | $-869.0K | $-373.0K | $19M | $6M | $-6M | $9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-27M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.9% | 20.2% | · | 40.9% | 60.1% | 23.9% | · | 25.4% | 1.2% | -23.6% | -15.9% | -19.6% | -48.8% | -82.1% | -43.5% | -156.9% | |
| Net Margin | 22.0% | 14.7% | · | 40.2% | 58.6% | 21.5% | · | 22.5% | -2.8% | -27.9% | -20.2% | -24.6% | -51.9% | -85.0% | -45.2% | -164.0% | |
| Pretax Margin | 30.0% | 19.8% | · | 39.8% | 59.0% | 21.6% | · | · | · | · | · | · | · | -85.0% | -45.2% | -164.0% | |
| EBITDA Margin | 29.9% | 21.2% | · | 40.9% | 60.1% | 25.1% | · | 25.4% | 1.2% | -22.2% | -15.9% | -19.6% | -47.4% | -82.1% | -43.5% | -155.5% | |
| ROA | 4.8% | 2.5% | · | 14.6% | 35.6% | 7.6% | · | 9.8% | -0.84% | -6.6% | -4.9% | -5.4% | -9.9% | -12.6% | -8.2% | -15.0% | |
| ROE | 6.8% | 4.1% | · | 54.2% | 229.2% | -174.7% | · | -53.5% | 3.5% | 29.5% | 22.0% | 41.5% | 155.1% | -127.6% | -41.9% | -64.5% | |
| ROIC | 4.1% | 2.2% | · | 24.4% | 74.1% | 68.4% | · | · | · | · | · | · | · | 92.8% | 352.6% | -386.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.6 | · | 2.3 | 2.0 | 2.2 | · | 2.0 | 1.6 | 1.3 | 2.0 | 2.3 | 2.4 | 2.3 | 2.2 | 2.3 | |
| Quick Ratio | 1.6 | 2.2 | · | 1.9 | 1.7 | 1.8 | · | 1.7 | 1.3 | 1.1 | 1.8 | 1.9 | 1.9 | 2.1 | 1.9 | 2.1 | |
| Interest Coverage | · | · | · | 15.0 | 32.6 | 6.9 | · | 6.8 | 0.2 | -3.7 | -2.4 | -2.8 | -10.6 | -22.3 | -22.8 | -21.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.4 | 0.6 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | |
| Inventory Turnover | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.8 | · | 1.5 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.2 | 0.0 | |
| Receivables Turnover | 1.6 | 1.3 | · | 1.8 | 3.0 | 1.5 | · | 2.0 | 1.5 | 1.0 | 1.4 | 1.4 | 1.2 | 1.5 | 1.7 | 0.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $4.02 | $2.99 | · | $3.63 | $5.60 | $2.94 | · | $3.13 | $2.10 | $0.17 | $0.16 | $0.15 | $0.15 | $0.13 | $0.17 | $0.10 | |
| Cash Flow / Share | · | $0.14 | · | · | · | $-0.05 | · | · | · | $-0.03 | · | · | $-0.02 | · | · | $-0.15 | |
| EPS (TTM) | $16.89 | $19.29 | · | $6.19 | $5.43 | $2.09 | · | $-0.48 | $-1.51 | $-1.83 | $-3.88 | $-3.66 | $-3.36 | $-0.48 | $-0.49 | $-0.49 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277M | $300M | · | $282M | $268M | $203M | · | $157M | $130M | $120M | $132M | $127M | $130M | $89M | $89M | $85M | |
| Net Income TTM | $322M | $364M | · | $113M | $98M | $37M | · | $4M | $-14M | $-20M | $-24M | $-38M | $-45M | $-83M | $-85M | $-85M | |
| P/E | 2.3 | 1.4 | · | 4.6 | 3.4 | 8.6 | · | -33.7 | -5.4 | -8.1 | -2.8 | -3.5 | -3.9 | -24.6 | -23.1 | -61.0 | |
| Earnings Yield | 43.2% | 71.3% | · | 21.9% | 29.0% | 11.6% | · | -3.0% | -18.4% | -12.4% | -35.9% | -28.4% | -25.4% | -4.1% | -4.3% | -1.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $294M | $179M | $117M | $120M | $149M |
| Betriebsgewinnmarge % | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% |
| Nettoergebnis | $367M | $17M | $-25M | $-59M | $-18M |
| Verwässerte EPS | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.4 | 2.1 | 1.9 | 1.8 | 2.4 |
| Quick Ratio | 2.1 | 1.9 | 1.6 | 1.5 | 2.2 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | · | $-74M | $5M |
Institutionelle Eigentümer (13F) 169 Einreicher · $637.8M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
169
Gehaltener Wert
$637.8M
Neue Positionen
31
Geschlossene Positionen
23
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 31 (+13 vs. Vorquartal) | 23 (-21 vs. Vorquartal) | 53 (-15 vs. Vorquartal) | 57 (+9 vs. Vorquartal) | +269K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $75.885.690 | 1.939.818 | 11,90% | Aktien |
| Soleus Capital Management, L.P. | $72.117.876 | 1.843.504 | 11,31% | Aktien |
| ARMISTICE CAPITAL, LLC | $65.408.640 | 1.672.000 | 10,26% | Aktien |
| VANGUARD GROUP INC | $44.475.015 | 1.038.408 | 6,97% | Aktien |
| STATE STREET CORP | $40.684.565 | 1.039.994 | 6,38% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.713.386 | 785.107 | 4,82% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $29.016.008 | 741.718 | 4,55% | Aktien |
| D. E. Shaw & Co., Inc. | $21.224.126 | 542.539 | 3,33% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $18.906.353 | 483.175 | 2,96% | Aktien |
| MARSHALL WACE, LLP | $14.372.414 | 367.393 | 2,25% | Aktien |
| CM Management, LLC | $9.780.000 | 250.000 | 1,53% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.143.439 | 233.728 | 1,43% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $8.917.295 | 227.951 | 1,40% | Aktien |
| GOLDMAN SACHS GROUP INC | $8.871.634 | 226.780 | 1,39% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $8.120.451 | 207.578 | 1,27% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $7.628.000 | 195.000 | 1,20% | Aktien |
| MORGAN STANLEY | $7.278.237 | 186.049 | 1,14% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6.049.008 | 154.627 | 0,95% | Aktien |
| NORTHERN TRUST CORP | $5.726.425 | 146.381 | 0,90% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $5.705.496 | 145.846 | 0,89% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $5.131.644 | 131.177 | 0,80% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $4.882.214 | 124.801 | 0,77% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $4.858.078 | 124.184 | 0,76% | Aktien |
| Nuveen, LLC | $4.849.354 | 123.961 | 0,76% | Aktien |
| BANK OF AMERICA CORP /DE/ | $4.831.556 | 123.506 | 0,76% | Aktien |
| FRANKLIN RESOURCES INC | $4.825.999 | 123.364 | 0,76% | Aktien |
| UBS Group AG | $4.809.960 | 122.954 | 0,75% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.762.195 | 121.733 | 0,75% | Aktien |
| GLOBEFLEX CAPITAL L P | $4.407.729 | 112.672 | 0,69% | Aktien |
| CenterBook Partners LP | $4.286.574 | 109.575 | 0,67% | Aktien |
| Bank of New York Mellon Corp | $4.233.132 | 108.209 | 0,66% | Aktien |
| FMR LLC | $3.759.903 | 96.112 | 0,59% | Aktien |
| RITHOLTZ WEALTH MANAGEMENT | $3.694.884 | 94.450 | 0,58% | Aktien |
| JANUS HENDERSON GROUP PLC | $3.674.114 | 135.877 | 0,58% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.665.114 | 93.689 | 0,57% | Aktien |
| FIRST TRUST ADVISORS LP | $3.182.099 | 81.342 | 0,50% | Aktien |
| Empowered Funds, LLC | $3.097.678 | 79.184 | 0,49% | Aktien |
| Brandywine Global Investment Management, LLC | $3.065.343 | 71.570 | 0,48% | Aktien |
| Russell Investments Group, Ltd. | $2.973.196 | 76.002 | 0,47% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.687.544 | 68.700 | 0,42% | Kaufoption |
| Squarepoint Ops LLC | $2.607.661 | 66.658 | 0,41% | Aktien |
| BURNEY CO/ | $2.181.683 | 55.769 | 0,34% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2.159.424 | 55.200 | 0,34% | Aktien |
| WELLS FARGO & COMPANY/MN | $2.131.727 | 54.492 | 0,33% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $2.032.088 | 51.945 | 0,32% | Aktien |
| OMERS ADMINISTRATION Corp | $2.030.328 | 51.900 | 0,32% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.989.800 | 50.864 | 0,31% | Aktien |
| Woodline Partners LP | $1.956.000 | 50.000 | 0,31% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $1.920.636 | 49.096 | 0,30% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $1.794.747 | 45.878 | 0,28% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 27. Januar 2005 | · | Erste Einreichung | Passive Anlage | SEC |
| I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE II, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM II, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FRAZIER AFFILIATES IV, L.P.., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER MANAGEMENT, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER & COMPANY, INC., I.R.S.Identification Nos. of above persons (entities only). ALAN D. FRAZIER | 14. April 2004 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 7. Juli 2003 | · | Erste Einreichung | Vorstandskampagne | SEC |
| MPM BioVentures III, L.P., MPM BioVentures III-QP, L.P., MPM BioVentures III Parallel Fund, L.P., MPM BioVentures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM BioVentures III GP, LP, MPM BioVentures III LLC, MPM BioEquities GP, LP, MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nick Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler | 7. Juli 2003 | · | Erste Einreichung | Vorstandskampagne | SEC |
| MPM Bio Ventures III, L.P., MPM Bio Ventures III-QP, L.P., MPM Bio Ventures III Parallel Fund, L.P., MPM Bio Ventures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM Bio Ventures III GP, L.P., MPM Bio Ventures III LLC, MPM BioEquities GP, L.P., MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler | 14. Mai 2003 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 41 Insider · 20 Führungskräfte · 20 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Raul R Rodriguez | CEO, President | 1. September 2026 F | 273.362 | 0 | 0 | $0 |
| James M Gower | CEO & Board Chairman | 27. Februar 2014 A | 180.676 | 0 | 0 | $0 |
| Dean L Schorno | EVP & Chief Financial Officer | 2. September 2026 M | 82.962 | 0 | 0 | $0 |
| Ryan D Maynard | EVP & CFO | 3. November 2017 M | 0 | 0 | 0 | $0 |
| James H Welch | CFO, VP & Secretary | 25. Januar 2006 A | 3.757 | 0 | 0 | $0 |
| David A Santos | EVP, Chief Commercial Officer | 1. September 2026 F | 61.622 | 0 | 0 | $0 |
| Raymond J. Furey | EVP, GC, CCO & Corp Sec | 1. September 2026 F | 50.559 | 0 | 0 | $0 |
| Alison L. Hannah | EVP, Chief Medical Officer | 8. Juli 2026 A | 35.025 | 0 | 0 | $0 |
| Lisa Rojkjaer | EVP, Chief Medical Officer | 17. Juni 2026 A | 34.003 | 0 | 0 | $0 |
| Wolfgang Dummer | EVP & CMO | 2. Februar 2023 S | 72.459 | 0 | 0 | $0 |
| Dolly Vance | EVP Corp. Affairs, G.C., Sect. | 14. September 2022 A | 60.260 | 0 | 0 | $0 |
| Nelson Cabatuan | VP,Finance & Princ.Acctg. Off. | 14. Mai 2020 A | 58 | 0 | 0 | $0 |
| Eldon C. Mayer III | EVP & Chief Commercial Officer | 18. November 2019 A | 215.000 | 0 | 0 | $0 |
| Joseph Lasaga | Sr.VP Bus.Dev.Alliance Mgmt. | 18. November 2019 A | · | 0 | 0 | $0 |
| Esteban Masuda | Sr. VP Research | 18. November 2019 S | · | 0 | 0 | $0 |
| Stacy Markel | EVP Human Resources | 20. März 2019 A | · | 0 | 0 | $0 |
| Anne-Marie Duliege | EVP & Chief Medical Officer | 20. März 2019 A | 0 | 0 | 0 | $0 |
| Donald G Payan | EVP, Pres. Discovery&Research | 30. August 2016 S | 53.031 | 0 | 0 | $0 |
| Elliot B Grossbard | EVP, CMO | 26. Januar 2016 A | 2.000 | 0 | 0 | $0 |
| Robin D G Cooper | Sr. V.P. Pharmaceutical Scs. | 31. Januar 2008 A | 9.000 | 0 | 0 | $0 |
| Kamil Ali-Jackson | Direktor | 22. Juni 2026 S | 10.125 | 0 | 2 | $-160.425 |
| Mark W Frohlich | Direktor | 15. Mai 2026 A | 7.000 | 0 | 0 | $0 |
| Jane Wasman | Direktor | 15. Mai 2026 A | 18.250 | 0 | 0 | $0 |
| Anthony Gregg Lapointe | Direktor | 15. Mai 2026 A | 18.250 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | Direktor | 15. Mai 2026 A | 5.937 | 0 | 0 | $0 |
| Walter H Moos | Direktor | 15. Mai 2026 A | 18.472 | 0 | 1 | $-145.440 |
| Brian L. Kotzin | Direktor | 25. Mai 2024 A | 100.000 | 0 | 0 | $0 |
| LYONS GARY A | Direktor | 26. Mai 2023 A | 75.000 | 0 | 0 | $0 |
| Keith Katkin | Direktor | 19. Mai 2021 A | 25.000 | 0 | 0 | $0 |
| Bradford S Goodwin | Direktor | 19. Mai 2021 A | 35.000 | 0 | 0 | $0 |
| Peter S Ringrose | Direktor | 17. Mai 2018 A | · | 0 | 0 | $0 |
| SHERWIN STEPHEN A | Direktor | 11. Mai 2016 A | · | 0 | 0 | $0 |
| Hollings Renton | Direktor | 15. Mai 2013 A | · | 0 | 0 | $0 |
| Jean Deleage | Direktor | 28. Mai 2010 A | 697 | 0 | 0 | $0 |
| Alan D Frazier | Direktor | 7. August 2006 A | 10.905 | 0 | 0 | $0 |
| Nicholas J Simon III | Direktor | 3. Juni 2005 A | 0 | 0 | 0 | $0 |
| Dennis Henner | Direktor | 5. Januar 2005 S | 0 | 0 | 0 | $0 |
| Michael Steinmetz | 10%-Eigentümer | 2. August 2004 S | 1.833.597 | 0 | 0 | $0 |
| Nicholas Galakatos | 10%-Eigentümer | 2. Juli 2004 S | 1.833.597 | 0 | 0 | $0 |
| Luke Evnin | 10%-Eigentümer | 2. Juli 2004 S | 1.833.597 | 0 | 0 | $0 |
| ANSBERT GADICKE | 10%-Eigentümer | 2. Juli 2004 J | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 31 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,54% | 41.313 NS | 31. Juli 2026 | N-PORT |
| IDNA · iShares Trust | 0,82% | 44.383 SH | 11. September 2026 | Täglich |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 2.596 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,21% | 62.481 SH | 11. September 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 29.124 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,16% | 22.093 NS | 31. Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,13% | 23.978 SH | 19. August 2026 | Täglich |
| CALF · Pacer Funds Trust | 0,09% | 84.790 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,06% | 136.671 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 1.309 SH | 1. Oktober 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 27.549 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 15.998 SH | 19. August 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,05% | 302 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 473.179 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 12.648 SH | 1. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 8.801 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 105.855 SH | 19. August 2026 | Täglich |
| TECB · iShares Trust | 0,02% | 1.868 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 619 SH | 1. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 212.359 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 54.159 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 32.659 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 6.553 SH | 9. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 16.178 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 22.835 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 3.010 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 699 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 555.846 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.629 SH | 19. August 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,00% | 112 NS | 31. Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 171.420 SH | 11. September 2026 | Täglich |
RIGL Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$55.00
+16,6%
4 36,4%
Starker Kauf
4 36,4%
Kauf
3 27,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-09-28Mittelwert-Ziel $63.00 +33,6%
Jetzt
Aktueller Preis $47.15
Tief$43.00
Mittelwert$63.00
Hoch$85.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| OBX | · | · | · | · | · | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Um 66 % gefallen, sollten Sie den Rückgang bei Rigetti Computing kaufen?
Nasdaq · 4 Monate, 2 Wochen vor
Rigel Pharma Schließt Lizenzvereinbarung mit Arvinas und Pfizer für Veppanu
Nasdaq · 4 Monate, 3 Wochen vor
Rigel Pharmaceuticals Inc. Gewinn im 1. Quartal gesunken
Nasdaq · 4 Monate, 3 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026